NOD2 and dysautonomia: It is uncertain whether gastrointestinal dysmotility, dysautonomia (e.g., POTS, orthostasis), and mast cell activation disorder are comorbidities or mechanistically related to NOD2 variants or the diagnosis of YAOS.